Lithuania - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)

Since 2014, Lithuania Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) grew 5.3% year on year. In 2019, the country was ranked number 17 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) at €91.16 Per Capita. Lithuania is overtaken by Estonia, which was ranked number 16 with €112.62 Per Capita and is followed by Romania with €70.44 Per Capita. Switzerland topped the ranking with €665.57 Per Capita in 2019, that is a growth of 3.2% versus 2018. Germany, Liechtenstein and Belgium respectively ranked number 2, 3 and 4 in this ranking. Switzerland witnessed the best average annual growth at +5.4% per year, while Portugal recorded the worst performance at -12.9% per year.

Loading...

Date Euros Per Capita
2019 91.16
2018 90.37
2017 83.53
2016 80.79
2015 73.57
Download all data from 2006 to 2019

How does Lithuania rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?

# 23 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
665.57 2019 +3.1 % +5.3 % View data
2 #2
Germany
524.79 2019 +2.3 % +3.0 % View data
16 #16
Estonia
112.62 2019 +2.9 % +5.0 % View data
17 #17
Lithuania
91.16 2019 +0.9 % +5.3 % View data
18 #18
Romania
70.44 2019 -1.6 % -1.7 % View data
Compare all 23 countries

Go Top